Aripiprazole in the treatment of paliperidone-induced tardive dyskinesia
Journal of the Scientific Society · 2015 · 42 (3) · 204
DOI: 10.4103/0974-5009.165582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Scientific Society, 2015. Verfasst von SameerBelvi Mangalwedhe und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Tardive dyskinesia (TD) is a potentially serious and irreversible side effect of anti-psychotic medications. It is characterized by choreiform movements, or rhythmic abnormal involuntary movements of the face, mouth, tongue, trunk, and limbs. Although no reliable treatment for TD exists, atypical anti-psychotics are associated with a significantly lower incidence of TD than typical anti-psychotics. Recent reports suggest that atypical anti-psychotics may have a beneficial effect on TD remission. We present a case of severe oro-bucco-lingual TD, which was effectively managed with aripiprazole.
Zitieren
APA
Mangalwedhe, S., Mahadevaiah, M., Pandurangi, A., & Nayak, R. (2015). Aripiprazole in the treatment of paliperidone-induced tardive dyskinesia. Journal of the Scientific Society, 42(3), 204. https://doi.org/10.4103/0974-5009.165582
Vancouver
Mangalwedhe S, Mahadevaiah M, Pandurangi A, Nayak R. Aripiprazole in the treatment of paliperidone-induced tardive dyskinesia. Journal of the Scientific Society. 2015;42(3):204. doi:10.4103/0974-5009.165582
BibTeX
@article{Mangalwedhe2015,
author = {Mangalwedhe, SameerBelvi and Mahadevaiah, Mahesh and Pandurangi, Aditya and Nayak, RaghavendraB},
title = {Aripiprazole in the treatment of paliperidone-induced tardive dyskinesia},
journal = {Journal of the Scientific Society},
year = {2015},
volume = {42},
number = {3},
pages = {204},
doi = {10.4103/0974-5009.165582}
}
EUVIMED